ePlus inc. (NASDAQ:PLUS) Shareholders Set to Receive $0.27 Quarterly Dividend
by Teresa Graham · The Cerbat GemePlus inc. (NASDAQ:PLUS – Get Free Report) announced a quarterly dividend on Thursday, November 5th. Stockholders of record on Tuesday, November 24th will be given a dividend of $0.27 per share by the software maker on Wednesday, December 16th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Tuesday, November 24th.
ePlus Stock Performance
PLUS opened at $82.43 on Friday. The company has a market capitalization of $2.15 billion, a PE ratio of 18.04, a P/E/G ratio of 1.16 and a beta of 0.95. The stock’s fifty day moving average is $91.82 and its 200-day moving average is $85.79. ePlus has a one year low of $72.93 and a one year high of $98.21.
ePlus (NASDAQ:PLUS – Get Free Report) last announced its earnings results on Thursday, November 5th. The software maker reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.35. ePlus had a return on equity of 11.51% and a net margin of 4.91%. The business had revenue of $667.92 million during the quarter, compared to analysts’ expectations of $636.10 million. On average, equities research analysts forecast that ePlus will post 4.86 EPS for the current fiscal year.
About ePlus
ePlus inc. (NASDAQ: PLUS) provides technology solutions, professional services and financing to organizations in the commercial, government, healthcare and education sectors. Through its technology business, the company helps customers plan, implement and manage information technology environments, including data center, networking, cybersecurity, collaboration, cloud and digital infrastructure solutions.
The company also offers managed and professional services, technology consulting, IT asset management, and lifecycle services.
Read More
- Five stocks we like better than ePlus
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch